Stefan Endres
6Patents
2h-index
12Co-inventors
44Inventor score
Filing activity: Dec 9, 2005 → Apr 2, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8003619B2 | Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide | Chemistry; Metallurgy | 15 | Expired |
| US10633451B2 | Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine | Emerging Cross-Sectional Technologies | 4 | Active |
| US11192935B2 | PD-1-CD28 fusion proteins and their use in medicine | Chemistry; Metallurgy | 1 | Active |
| US11732052B2 | Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine | Emerging Cross-Sectional Technologies | 1 | Active |
| US11547748B2 | Adoptive t-cell therapy | Chemistry; Metallurgy | 0 | Active |
| US11723922B2 | CXCR6-transduced T cells for targeted tumor therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.